New hope for brain cancer: experimental combo targets glioblastoma
NCT ID NCT04752813
First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This study tests whether adding an experimental drug called BPM31510 (with vitamin K1) to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 50 adults will receive the combination, and researchers will track how long the cancer stays under control and overall survival. The goal is to see if the added drug improves outcomes without causing severe side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Inova
Fairfax, Virginia, 22037, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
Sansum Clinic
Santa Barbara, California, 93105, United States
-
Stanford University Cancer Center
Palo Alto, California, 94305, United States
-
Texas Oncology
Austin, Texas, 78705, United States
-
UT Health San Antonio Mays Cancer Center
San Antonio, Texas, 78229, United States
-
Valley Health
Ridgewood, New Jersey, 07450, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.